Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Despite recent advances in both surgery and chemoradiotherapy, mortality rates for advanced cancer remain high. There is a pressing need for novel therapeutic strategies; one option is systemic oncolytic viral therapy. Intravenous administration affords the opportunity to treat both the primary tum...
Saved in:
| Main Authors: | Mark S. Ferguson, Nicholas R. Lemoine, Yaohe Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Advances in Virology |
| Online Access: | http://dx.doi.org/10.1155/2012/805629 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanding horizons of cancer immunotherapy: hopes and hurdles
by: Priyanka Vijay Sonar, et al.
Published: (2025-04-01) -
GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer
by: Yujing Xuan, et al.
Published: (2025-01-01) -
Oncolytic virus VG161 offers new hope for refractory liver cancer
by: Jinqiu Li, et al.
Published: (2025-07-01) -
A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer
by: Lijuan Chen, et al.
Published: (2025-01-01) -
Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer
by: Wenyi Yan, et al.
Published: (2025-04-01)